Hearing quality restored with bionic ear technology used for gene therapy

April 23, 2014, University of New South Wales
Image of the inside of the cochlea after DNA delivery. The green spots show the location of cells that are expressing the therapeutic gene, which is close to where the cochlear implant electrodes were positioned. Credit: UNSW Australia Translational Neuroscience Facility, J. Pinyon and G. Housley

Researchers at UNSW Australia have for the first time used electrical pulses delivered from a cochlear implant to deliver gene therapy, thereby successfully regrowing auditory nerves.

The research also heralds a possible new way of treating a range of neurological disorders, including Parkinson's disease, and psychiatric conditions such as depression through this novel way of delivering .

The research is published today (Thursday 24 April) in the journal Science Translational Medicine.

"People with do well with understanding speech, but their perception of pitch can be poor, so they often miss out on the joy of music," says UNSW Professor Gary Housley, who is the senior author of the research paper.

"Ultimately, we hope that after further research, people who depend on cochlear implant devices will be able to enjoy a broader dynamic and tonal range of sound, which is particularly important for our sense of the auditory world around us and for music appreciation," says Professor Housley, who is also the Director of the Translational Neuroscience Facility at UNSW Medicine.

The research, which has the support of Cochlear Limited through an Australian Research Council Linkage Project grant, has been five years in development.

This shows regenerated auditory nerves after gene therapy (top) compared with no treatment (below). Credit: UNSW Translational Neuroscience Facility

The work centres on regenerating surviving nerves after age-related or environmental hearing loss, using existing cochlear technology. The cochlear implants are "surprisingly efficient" at localised gene therapy in the animal model, when a few electric pulses are administered during the implant procedure.

"This research breakthrough is important because while we have had very good outcomes with our cochlear implants so far, if we can get the nerves to grow close to the electrodes and improve the connections between them, then we'll be able to have even better outcomes in the future," says Jim Patrick, Chief Scientist and Senior Vice-President, Cochlear Limited.

It has long been established that the auditory nerve endings regenerate if neurotrophins – a naturally occurring family of proteins crucial for the development, function and survival of neurons – are delivered to the auditory portion of the inner ear, the cochlea.

But until now, research has stalled because safe, localised delivery of the neurotrophins can't be achieved using drug delivery, nor by viral-based gene therapy.

Professor Housley and his team at UNSW developed a way of using delivered from the cochlear implant to deliver the DNA to the cells close to the array of implanted electrodes. These cells then produce neurotrophins.

"No-one had tried to use the cochlear implant itself for gene therapy," says Professor Housley. "With our technique, the cochlear implant can be very effective for this."

Video of the 3D confocal imaging of the inside of the cochlea after DNA delivery. The green spots show the location of cells that are expressing the therapeutic gene which is close to where the cochlear implant electrodes were positioned. Credit: UNSW Australia Translational Neuroscience Facility, J. Pinyon and G. Housley

While the neurotrophin production dropped away after a couple of months, Professor Housley says ultimately the changes in the hearing nerve may be maintained by the ongoing neural activity generated by the cochlear implant.

"We think it's possible that in the future this gene delivery would only add a few minutes to the implant procedure," says the paper's first author, Jeremy Pinyon, whose PhD is based on this work. "The surgeon who installs the device would inject the DNA solution into the cochlea and then fire electrical impulses to trigger the DNA transfer once the implant is inserted."

Integration of this technology into other 'bionic' devices such as electrode arrays used in deep brain stimulation (for the treatment of Parkinson's disease and depression, for example) could also afford opportunities for safe, directed gene therapy of complex neurological disorders.

"Our work has implications far beyond hearing disorders," says co-author Associate Professor Matthias Klugmann, from the UNSW Translational Neuroscience Facility research team. "Gene therapy has been suggested as a treatment concept even for devastating neurological conditions and our technology provides a novel platform for safe and efficient gene transfer into tissues as delicate as the brain."

Explore further: Design prototype chip makes possible a fully implantable cochlear implant

More information: "Close-Field Electroporation Gene Delivery Using the Cochlear Implant Electrode Array Enhances the Bionic Ear," by J.L. Pinyon et al. Science Translational Medicine, 2014.

Related Stories

Design prototype chip makes possible a fully implantable cochlear implant

February 10, 2014
Researchers from Massachusetts Eye and Ear, Harvard Medical School, and Massachusetts Institute of Technology (MIT) have designed a prototype system-on-chip (SoC) that could make possible a fully implanted cochlear implant. ...

World-first device offers new insight into life with a cochlear implant

October 30, 2013
A new imaging device will be launched on Macquarie University's campus today, helping researchers in the ARC Centre of Excellence in Cognition and its Disorders (CCD) and HEARing Cooperative Research Centre (CRC) better understand ...

New strategy lets cochlear implant users hear music

October 9, 2013
For many, music is a universal language that unites people when words cannot. But for those who use cochlear implants—technology that allows deaf and hard of hearing people to comprehend speech—hearing music remains extremely ...

Cochlear implants—with no exterior hardware

February 9, 2014
Cochlear implants—medical devices that electrically stimulate the auditory nerve—have granted at least limited hearing to hundreds of thousands of people worldwide who otherwise would be totally deaf. Existing versions ...

Researcher uses DNA therapy in lab mice to improve cochlear implant functionality

March 24, 2014
One in a thousand children in the United States is deaf, and one in three adults will experience significant hearing loss after the age of 65. Whether the result of genetic or environmental factors, hearing loss costs billions ...

Computer models of neuronal sound processing in the brain lead to cochlear implant improvements

December 2, 2013
Children learning to speak depend on functional hearing. So-called cochlear implants allow deaf people to hear again by stimulating the auditory nerve directly. Researchers at the Technische Universitaet Muenchen (TUM) are ...

Recommended for you

More surprises about blood development—and a possible lead for making lymphocytes

January 22, 2018
Hematopoietic stem cells (HSCs) have long been regarded as the granddaddy of all blood cells. After we are born, these multipotent cells give rise to all our cell lineages: lymphoid, myeloid and erythroid cells. Hematologists ...

How metal scaffolds enhance the bone healing process

January 22, 2018
A new study shows how mechanically optimized constructs known as titanium-mesh scaffolds can optimize bone regeneration. The induction of bone regeneration is of importance when treating large bone defects. As demonstrated ...

Researchers illustrate how muscle growth inhibitor is activated, could aid in treating ALS

January 19, 2018
Researchers at the University of Cincinnati (UC) College of Medicine are part of an international team that has identified how the inactive or latent form of GDF8, a signaling protein also known as myostatin responsible for ...

Bioengineered soft microfibers improve T-cell production

January 18, 2018
T cells play a key role in the body's immune response against pathogens. As a new class of therapeutic approaches, T cells are being harnessed to fight cancer, promising more precise, longer-lasting mitigation than traditional, ...

Weight flux alters molecular profile, study finds

January 17, 2018
The human body undergoes dramatic changes during even short periods of weight gain and loss, according to a study led by researchers at the Stanford University School of Medicine.

Secrets of longevity protein revealed in new study

January 17, 2018
Named after the Greek goddess who spun the thread of life, Klotho proteins play an important role in the regulation of longevity and metabolism. In a recent Yale-led study, researchers revealed the three-dimensional structure ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.